Merck, Truist
Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...
The stock's fall snapped a two-day winning streak.
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...
This was the stock's second consecutive day of gains.
Serenity may feel hard to come by these days, but the natural world still offers solace for those willing to seek it.
GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...
Merck Forest & Farmland Center will be hosting two upcoming events, an Animal Tracking Hike on Saturday, January 11 from 10 a ...
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
24/7 Wall St. on MSN1d
Merck Just Paid Investors: How Much Did They Receive?Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback